piperidines and Ductus-Arteriosus--Patent

piperidines has been researched along with Ductus-Arteriosus--Patent* in 2 studies

Other Studies

2 other study(ies) available for piperidines and Ductus-Arteriosus--Patent

Article	Year
Target-controlled infusion of propofol combined with variable rate infusion of remifentanil for anaesthesia of a dog with patent ductus arteriosus. Veterinary anaesthesia and analgesia, 2007, Volume: 34, Issue:5 An 18-month-old Lurcher was anaesthetized for surgical ligation of a patent ductus arteriosus using a target-controlled infusion (TCI) of propofol and a variable rate infusion of remifentanil. Before anaesthesia, radiographic and echocardiographic examination indicated that the dog had left-sided congestive heart failure and impaired left ventricular systolic function. Ramipril and furosemide were administered pre-operatively. Following pre-anaesthetic medication with morphine, 0.5 mg kg(-1), by intramuscular injection, and pre-oxygenation, remifentanil was infused for 5 minutes at 0.2 microg kg(-1) minute(-1), followed by induction of anaesthesia using intravenous propofol administered by TCI, set at a target concentration of 3.5 microg mL(-1) of propofol in blood. Tracheal intubation was performed and 100% oxygen delivered through a non-rebreathing (Bain) system and then a circle system in the operating theatre. Anaesthesia was maintained with propofol and remifentanil, adjusted according to clinical requirements. Peri-operative analgesia consisted of intercostal bupivacaine nerve block, with meloxicam, morphine and remifentanil. Topics: Anesthesia; Anesthetics, Combined; Anesthetics, Intravenous; Animals; Dog Diseases; Dogs; Ductus Arteriosus, Patent; Female; Infusions, Intravenous; Piperidines; Propofol; Remifentanil	2007
Use of remifentanil in infants. Paediatric anaesthesia, 1998, Volume: 8, Issue:5 We describe the use of remifentanil in three infants with complex medical issues (hepatic failure, cyanotic heart disease and renal compromise). The short duration of opioid effect even after a long period of drug infusion (18 h) suggests this drug may be useful in some infants. Continued study is warranted. Topics: Analgesics, Opioid; Down Syndrome; Ductus Arteriosus, Patent; Endocardial Cushion Defects; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Infant, Premature; Intubation, Intratracheal; Kidney Diseases; Liver Failure; Male; Piperidines; Remifentanil; Rubinstein-Taybi Syndrome	1998

Article

Year

Target-controlled infusion of propofol combined with variable rate infusion of remifentanil for anaesthesia of a dog with patent ductus arteriosus.

Veterinary anaesthesia and analgesia, 2007, Volume: 34, Issue:5

An 18-month-old Lurcher was anaesthetized for surgical ligation of a patent ductus arteriosus using a target-controlled infusion (TCI) of propofol and a variable rate infusion of remifentanil. Before anaesthesia, radiographic and echocardiographic examination indicated that the dog had left-sided congestive heart failure and impaired left ventricular systolic function. Ramipril and furosemide were administered pre-operatively. Following pre-anaesthetic medication with morphine, 0.5 mg kg(-1), by intramuscular injection, and pre-oxygenation, remifentanil was infused for 5 minutes at 0.2 microg kg(-1) minute(-1), followed by induction of anaesthesia using intravenous propofol administered by TCI, set at a target concentration of 3.5 microg mL(-1) of propofol in blood. Tracheal intubation was performed and 100% oxygen delivered through a non-rebreathing (Bain) system and then a circle system in the operating theatre. Anaesthesia was maintained with propofol and remifentanil, adjusted according to clinical requirements. Peri-operative analgesia consisted of intercostal bupivacaine nerve block, with meloxicam, morphine and remifentanil.

Topics: Anesthesia; Anesthetics, Combined; Anesthetics, Intravenous; Animals; Dog Diseases; Dogs; Ductus Arteriosus, Patent; Female; Infusions, Intravenous; Piperidines; Propofol; Remifentanil

2007

Use of remifentanil in infants.

Paediatric anaesthesia, 1998, Volume: 8, Issue:5

We describe the use of remifentanil in three infants with complex medical issues (hepatic failure, cyanotic heart disease and renal compromise). The short duration of opioid effect even after a long period of drug infusion (18 h) suggests this drug may be useful in some infants. Continued study is warranted.

Topics: Analgesics, Opioid; Down Syndrome; Ductus Arteriosus, Patent; Endocardial Cushion Defects; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Infant, Premature; Intubation, Intratracheal; Kidney Diseases; Liver Failure; Male; Piperidines; Remifentanil; Rubinstein-Taybi Syndrome

1998